Abstract
Metastatic breast cancer to brain carries poor prognostic features with increased risks of occurrence in Tripple- negative and HER- positive breast tumors. In addition, tumors with mutated BRCA tumors, carry as well increased metastatic incidence. However, new clinical evidence suggest distinct clinical features between BRCA1 or BRCA2 mutated breast cancer and brain metastasis. Review of literature may help characterize the distinctive differences between BRCA1 or BRCA2 breast tumors and subsequent metastasis to brain.
Keywords
Breast cancer, Brain metastasis, BRCA1, BRCA2, Mutation, Triple-negative, Hormone -receptor positive, Pathogenic variant, Prognosis, Early breast cancer